Interestingly, we reversed the effects of HTR1D on pancreatic cancer using MK-2206, indicating that the effect of HTR1D on pancreatic cancer, at least in part, was mediated by the PI3K-AKT signaling pathway (Fig. 3b). The gene discussed is AKT1; the disease is pancreatic neoplasm.